Decision-making impact on adjuvant chemotherapy allocation in early node-negative breast cancer with a 21-gene assay: systematic review and meta-analysis

/ 2015, CIESP, Evaluación de Tecnologías Sanitarias, Publicaciones Científicas, Salud de la Madre y el Niño / Por

F. Augustovski,N. Soto,J. Caporale,L. Gonzalez,L. Gibbons and A. Ciapponi. Decision-making impact on adjuvant chemotherapy allocation in early node-negative breast cancer with a 21-gene assay: systematic review and meta-analysis. Breast Cancer Res Treat. 2015;152(3):10.1007/s10549-015-3483-3.

Ir a la publicación